BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30191997)

  • 1. Antioxidative potential of antidiabetic agents: A possible protective mechanism against vascular complications in diabetic patients.
    Yaribeygi H; Butler AE; Barreto GE; Sahebkar A
    J Cell Physiol; 2019 Mar; 234(3):2436-2446. PubMed ID: 30191997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT1 Antagonizes Oxidative Stress in Diabetic Vascular Complication.
    Meng T; Qin W; Liu B
    Front Endocrinol (Lausanne); 2020; 11():568861. PubMed ID: 33304318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the anti-inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes.
    Yaribeygi H; Atkin SL; Pirro M; Sahebkar A
    J Cell Physiol; 2019 Jun; 234(6):8286-8294. PubMed ID: 30417367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of sulphoraphane against vascular complications in diabetes.
    Yamagishi S; Matsui T
    Pharm Biol; 2016 Oct; 54(10):2329-39. PubMed ID: 26841240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonols in the Prevention of Diabetes-induced Vascular Dysfunction.
    Leo CH; Woodman OL
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):532-44. PubMed ID: 25387248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease.
    Jakus V
    Bratisl Lek Listy; 2000; 101(10):541-51. PubMed ID: 11218944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium-glucose cotransporter inhibitors and oxidative stress: An update.
    Yaribeygi H; Atkin SL; Butler AE; Sahebkar A
    J Cell Physiol; 2019 Apr; 234(4):3231-3237. PubMed ID: 30443936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bonus Effects of Antidiabetic Drugs: Possible Beneficial Effects on Endothelial Dysfunction, Vascular Inflammation and Atherosclerosis.
    Pereira CA; Carneiro FS; Matsumoto T; Tostes RC
    Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):523-538. PubMed ID: 29890033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of Vascular Complications in Diabetes Mellitus Patients: Focus on the Arterial Wall.
    Lunder M; Janić M; Šabovič M
    Curr Vasc Pharmacol; 2019; 17(1):6-15. PubMed ID: 29412116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antioxidants in the combined therapy of diabetic angiopathies].
    Bobyreva LE
    Eksp Klin Farmakol; 1998; 61(1):74-80. PubMed ID: 9575419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of oxidative stress and potential role of natural antioxidants in diabetic vascular complications.
    Ceriello A; Testa R; Genovese S
    Nutr Metab Cardiovasc Dis; 2016 Apr; 26(4):285-92. PubMed ID: 27036849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity.
    Oelze M; Kröller-Schön S; Welschof P; Jansen T; Hausding M; Mikhed Y; Stamm P; Mader M; Zinßius E; Agdauletova S; Gottschlich A; Steven S; Schulz E; Bottari SP; Mayoux E; Münzel T; Daiber A
    PLoS One; 2014; 9(11):e112394. PubMed ID: 25402275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications.
    Meng B; Li J; Cao H
    Curr Pharm Des; 2013; 19(11):2101-13. PubMed ID: 23116316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antioxidant and anti-AGE therapeutics: evaluation and perspectives].
    Bonnefont-Rousselot D
    J Soc Biol; 2001; 195(4):391-8. PubMed ID: 11938556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nigella sativa improves glycemic control and ameliorates oxidative stress in patients with type 2 diabetes mellitus: placebo controlled participant blinded clinical trial.
    Kaatabi H; Bamosa AO; Badar A; Al-Elq A; Abou-Hozaifa B; Lebda F; Al-Khadra A; Al-Almaie S
    PLoS One; 2015; 10(2):e0113486. PubMed ID: 25706772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin Therapy, Insulin Resistance and Vascular Dysfunction.
    Vázquez MC; Sobrevia L
    Curr Vasc Pharmacol; 2019; 17(5):429-431. PubMed ID: 31418345
    [No Abstract]   [Full Text] [Related]  

  • 17. Antidiabetic and renoprotective effect of Anogeissus acuminata leaf extract on experimentally induced diabetic nephropathy.
    Navale AM; Paranjape A
    J Basic Clin Physiol Pharmacol; 2018 Jul; 29(4):359-364. PubMed ID: 29617268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase.
    Shen GX
    Can J Physiol Pharmacol; 2010 Mar; 88(3):241-8. PubMed ID: 20393589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Natural Rotenoid Deguelin Ameliorates Diabetic Neuropathy by Decreasing Oxidative Stress and Plasma Glucose Levels in Rats via the Nrf2 Signalling Pathway.
    Chen J; Liu W; Yi H; Hu X; Peng L; Yang F
    Cell Physiol Biochem; 2018; 48(3):1164-1176. PubMed ID: 30045011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grape seed procyanidin b2 inhibits human aortic smooth muscle cell proliferation and migration induced by advanced glycation end products.
    Cai Q; Li BY; Gao HQ; Zhang JH; Wang JF; Yu F; Yin M; Zhang Z
    Biosci Biotechnol Biochem; 2011; 75(9):1692-7. PubMed ID: 21897042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.